137 related articles for article (PubMed ID: 27728817)
41. Recent progress in the development of Toll-like receptor (TLR) antagonists.
Patra MC; Choi S
Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061
[TBL] [Abstract][Full Text] [Related]
42. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
43. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity.
Kurt-Jones EA; Sandor F; Ortiz Y; Bowen GN; Counter SL; Wang TC; Finberg RW
J Endotoxin Res; 2004; 10(6):419-24. PubMed ID: 15588425
[TBL] [Abstract][Full Text] [Related]
44. Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.
Chung H; Watanabe T; Kudo M; Chiba T
J Viral Hepat; 2011 Oct; 18(10):e561-7. PubMed ID: 21914077
[TBL] [Abstract][Full Text] [Related]
45. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.
Dul M; Nikolic T; Stefanidou M; McAteer MA; Williams P; Mous J; Roep BO; Kochba E; Levin Y; Peakman M; Wong FS; Dayan CM; Tatovic D; Coulman SA; Birchall JC;
Int J Pharm; 2019 May; 562():303-312. PubMed ID: 30910633
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
47. Facile, rapid and efficient biofabrication of gold nanoparticles decorated with functional proteins.
Shimojo K; Niide T; Taguchi T; Naganawa H; Kamiya N; Goto M
Analyst; 2012 May; 137(10):2300-3. PubMed ID: 22430764
[TBL] [Abstract][Full Text] [Related]
48. Female sex hormones modulate Porphyromonas gingivalis lipopolysaccharide-induced Toll-like receptor signaling in primary human monocytes.
Jitprasertwong P; Charadram N; Kumphune S; Pongcharoen S; Sirisinha S
J Periodontal Res; 2016 Jun; 51(3):395-406. PubMed ID: 26364725
[TBL] [Abstract][Full Text] [Related]
49. Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles.
Rajchakit U; Sarojini V
Bioconjug Chem; 2017 Nov; 28(11):2673-2686. PubMed ID: 28892365
[TBL] [Abstract][Full Text] [Related]
50. Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil.
Patchett AL; Latham R; Brettingham-Moore KH; Tovar C; Lyons AB; Woods GM
Dev Comp Immunol; 2015 Nov; 53(1):123-33. PubMed ID: 26182986
[TBL] [Abstract][Full Text] [Related]
51. Mononuclear cells phagocytic activity affects the crosstalk between immune and cancer cells.
Djaldetti M; Bessler H
Biomed Pharmacother; 2014 Jul; 68(6):679-83. PubMed ID: 25194440
[TBL] [Abstract][Full Text] [Related]
52. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway.
Bhaskar S; Shalini V; Helen A
Immunobiology; 2011 Mar; 216(3):367-73. PubMed ID: 20828867
[TBL] [Abstract][Full Text] [Related]
53. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
54. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen.
Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF
J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958
[TBL] [Abstract][Full Text] [Related]
55. The immunomodulatory molecule pidotimod induces the expression of the NOD-like receptor NLRP12 and attenuates TLR-induced inflammation.
Fogli M; Caccuri F; Iaria ML; Giagulli C; Corbellini S; Campilongo F; Caruso A; Fiorentini S
J Biol Regul Homeost Agents; 2014; 28(4):753-66. PubMed ID: 25620184
[TBL] [Abstract][Full Text] [Related]
56. Highly specific targeting of human leukocytes using gold nanoparticle-based biologically active conjugates.
Gibbs BF; Yasinska IM; Calzolai L; Gilliland D; Sumbayev VV
J Biomed Nanotechnol; 2014 Jul; 10(7):1259-66. PubMed ID: 24804546
[TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
Lin YC; Huang DY; Chu CL; Lin WW
Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
[TBL] [Abstract][Full Text] [Related]
58. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
[TBL] [Abstract][Full Text] [Related]
59. Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats.
Bhaskar S; Helen A
Mol Cell Biochem; 2016 Dec; 423(1-2):53-65. PubMed ID: 27665434
[TBL] [Abstract][Full Text] [Related]
60. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation.
Gribar SC; Anand RJ; Sodhi CP; Hackam DJ
J Leukoc Biol; 2008 Mar; 83(3):493-8. PubMed ID: 18160540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
